Artificial, a Palo Alto-based startup, just announced a $21.5M funding round, including investment from M12, Microsoft’s venture fund, to further develop and commercialize its lab automation software.

The progress in laboratory automation could be one of the most consistent changes in research in the life sciences and biomedicine over the past 30 years. The evolution of this field borders on the ...